BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 19958356)

  • 1. The Haematological Malignancy Research Network (HMRN): a new information strategy for population based epidemiology and health service research.
    Smith A; Roman E; Howell D; Jones R; Patmore R; Jack A;
    Br J Haematol; 2010 Mar; 148(5):739-53. PubMed ID: 19958356
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence of haematological malignancy by sub-type: a report from the Haematological Malignancy Research Network.
    Smith A; Howell D; Patmore R; Jack A; Roman E
    Br J Cancer; 2011 Nov; 105(11):1684-92. PubMed ID: 22045184
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estimating the prevalence of hematological malignancies and precursor conditions using data from Haematological Malignancy Research Network (HMRN).
    Li J; Smith A; Crouch S; Oliver S; Roman E
    Cancer Causes Control; 2016 Aug; 27(8):1019-26. PubMed ID: 27351920
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Italian cancer figures--Report 2015: The burden of rare cancers in Italy.
    ; Busco S; Buzzoni C; Mallone S; Trama A; Castaing M; Bella F; Amodio R; Bizzoco S; Cassetti T; Cirilli C; Cusimano R; De Angelis R; Fusco M; Gatta G; Gennaro V; Giacomin A; Giorgi Rossi P; Mangone L; Mannino S; Rossi S; Pierannunzio D; Tavilla A; Tognazzo S; Tumino R; Vicentini M; Vitale MF; Crocetti E; Dal Maso L
    Epidemiol Prev; 2016; 40(1 Suppl 2):1-120. PubMed ID: 26951748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lymphoma incidence, survival and prevalence 2004-2014: sub-type analyses from the UK's Haematological Malignancy Research Network.
    Smith A; Crouch S; Lax S; Li J; Painter D; Howell D; Patmore R; Jack A; Roman E
    Br J Cancer; 2015 Apr; 112(9):1575-84. PubMed ID: 25867256
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lymphoid blood cancers, incidence and survival 2005-2023: A report from the UK's Haematological Malignancy Research Network.
    Lamb M; Painter D; Howell D; Barrans S; Cargo C; de Tute R; Tooze R; Burton C; Patmore R; Roman E; Smith A
    Cancer Epidemiol; 2024 Feb; 88():102513. PubMed ID: 38160571
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Italian cancer figures, report 2012: Cancer in children and adolescents.
    ; ;
    Epidemiol Prev; 2013; 37(1 Suppl 1):1-225. PubMed ID: 23585445
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment decision making (TDM): a qualitative study exploring the perspectives of patients with chronic haematological cancers.
    McCaughan D; Roman E; Smith A; Patmore R; Howell D
    BMJ Open; 2022 Mar; 12(3):e050816. PubMed ID: 35351694
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Survival for haematological malignancies in Europe between 1997 and 2008 by region and age: results of EUROCARE-5, a population-based study.
    Sant M; Minicozzi P; Mounier M; Anderson LA; Brenner H; Holleczek B; Marcos-Gragera R; Maynadié M; Monnereau A; Osca-Gelis G; Visser O; De Angelis R;
    Lancet Oncol; 2014 Aug; 15(9):931-42. PubMed ID: 25030467
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Time-to-diagnosis and symptoms of myeloma, lymphomas and leukaemias: a report from the Haematological Malignancy Research Network.
    Howell DA; Smith AG; Jack A; Patmore R; Macleod U; Mironska E; Roman E
    BMC Hematol; 2013 Oct; 13(1):9. PubMed ID: 24238148
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of novel therapies for mantle cell lymphoma in the real world setting: a report from the UK's Haematological Malignancy Research Network (HMRN).
    Smith A; Roman E; Appleton S; Howell D; Johnson R; Burton C; Patmore R
    Br J Haematol; 2018 Apr; 181(2):215-228. PubMed ID: 29532919
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidence and survival of lymphohematopoietic neoplasms according to the World Health Organization classification: a population-based study from the Victorian Cancer Registry in Australia.
    Jayasekara H; Karahalios A; Juneja S; Thursfield V; Farrugia H; English DR; Giles GG
    Leuk Lymphoma; 2010 Mar; 51(3):456-68. PubMed ID: 20141433
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emergency admission and survival from aggressive non-Hodgkin lymphoma: A report from the UK's population-based Haematological Malignancy Research Network.
    Kane E; Howell D; Smith A; Crouch S; Burton C; Roman E; Patmore R
    Eur J Cancer; 2017 Jun; 78():53-60. PubMed ID: 28412589
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cohort Profile Update: The Haematological Malignancy Research Network (HMRN) UK population-based cohorts.
    Roman E; Kane E; Howell D; Lamb M; Bagguley T; Crouch S; Painter D; Patmore R; Smith A
    Int J Epidemiol; 2022 Jun; 51(3):e87-e94. PubMed ID: 35134983
    [No Abstract]   [Full Text] [Related]  

  • 15. A Generic Model for Follicular Lymphoma: Predicting Cost, Life Expectancy, and Quality-Adjusted-Life-Year Using UK Population-Based Observational Data.
    Wang HI; Roman E; Crouch S; Aas E; Burton C; Patmore R; Smith A
    Value Health; 2018 Oct; 21(10):1176-1185. PubMed ID: 30314618
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence for a common genetic aetiology in high-risk families with multiple haematological malignancy subtypes.
    Tegg EM; Thomson RJ; Stankovich J; Banks A; Flowers C; McWhirter R; Panton J; Piaszczyk A; Bahlo M; Marsden KA; Lowenthal RM; Foote SJ; Dickinson JL
    Br J Haematol; 2010 Aug; 150(4):456-62. PubMed ID: 20560968
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term medical costs and life expectancy of acute myeloid leukemia: a probabilistic decision model.
    Wang HI; Aas E; Howell D; Roman E; Patmore R; Jack A; Smith A
    Value Health; 2014 Mar; 17(2):205-14. PubMed ID: 24636378
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence of haematological malignancies, Eastern Cape Province; South Africa, 2004-2013.
    Oelofse D; Truter I
    Cancer Epidemiol; 2018 Apr; 53():166-171. PubMed ID: 29462765
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Haematological cancers: improving outcomes. A summary of updated NICE service guidance in relation to Specialist Integrated Haematological Malignancy Diagnostic Services (SIHMDS).
    Snowden JA; O'Connell S; Hawkins J; Dalley C; Jack A; Mannari D; McNamara C; Scott M; Shenton G; Soilleux E; Macbeth F;
    J Clin Pathol; 2017 Jun; 70(6):461-468. PubMed ID: 28389440
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased risk of zoonotic Salmonella and Campylobacter gastroenteritis in patients with haematological malignancies: a population-based study.
    Gradel KO; Nørgaard M; Dethlefsen C; Schønheyder HC; Kristensen B; Ejlertsen T; Nielsen H
    Ann Hematol; 2009 Aug; 88(8):761-7. PubMed ID: 19083236
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.